Physician profile
Adam Kadlec
NPI 1447416243
$19,438.06
in general payments reported to CMS, 2019-2025
12 companies · $23.16 in 2025
The $23.16 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,722 · 2020: $798 · 2021: $14K · 2022: $1,617 · 2023: $188 · 2024: $52.57 · 2025: $23.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $13,417.53 | 2021-2022 | |
| Boston Scientific Corporation | $3,284.61 | 2019-2023 | Rezum Generator |
| Procept Biorobotics Corporation | $877.07 | 2020-2022 | |
| Verathon INC. | $800.00 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $757.34 | 2021-2022 | |
| Cook Medical LLC | $167.63 | 2019-2024 | Cook |
| Medtronic USA, INC. | $38.84 | 2019 | |
| Coloplast Corp | $31.13 | 2023 | |
| Myovant Sciences INC. | $27.25 | 2021 | |
| Stryker Corporation | $14.31 | 2025 | 1788 |
| Abbvie INC. | $13.50 | 2022 | |
| Minze Health, INC | $8.85 | 2025 | Minze Homeflow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Kadlec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.